Cargando…
Clinical and molecular impacts of tumor mutational burden in histological and cytological specimens from cancer patients
BACKGROUND: The tumor mutational burden (TMB) is a promising biomarker for immune checkpoint inhibitor (ICI). However, its relationships with clinical parameters have not been fully explored. We aimed to assess potential factors including age, microsatellite instability (MSI) state, tumor types, and...
Autores principales: | Li, Lin, Chen, Chuan, Liu, Chaojun, Niu, Li, Pan, Chunguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908122/ https://www.ncbi.nlm.nih.gov/pubmed/35280376 http://dx.doi.org/10.21037/atm-22-358 |
Ejemplares similares
-
Epidermal Growth Factor Receptor Gene Mutation Detection in Histology and Cytology Specimens of Primary Lung Adenocarcinoma: Immunohistochemistry Versus the Molecular Method
por: Abdul Hamid, Nurul Shuhada, et al.
Publicado: (2021) -
Effectiveness of histology and cytology on musculoskeletal tumor diagnosis
por: Lima, Pablo Moura de Andrade, et al.
Publicado: (2014) -
How to Mimic a Histological Sample Slide for RNAscope(TM) Applications from BAL Cytological Specimens
por: Morotti, Denise, et al.
Publicado: (2021) -
Improvization of conventional cytology by centrifuged liquid-based cytology in oral exfoliative cytology specimen
por: Nambiar, Shwetha, et al.
Publicado: (2016) -
Challenges in Cytology Specimens With Hürthle Cells
por: Thodou, Eleni, et al.
Publicado: (2021)